Central Kentucky Addiction Treatment

Central Kentucky Addiction Treatment

Services:
Facility Operation (e.g., Private, Public)
• Private for-profit organization

Facility Vaping Policy

• Vaping permitted in designated area

Recovery Support Services

• Mentoring/peer support

Gender Accepted

• Female
• Male

Type of Opioid Treatment

• Buprenorphine detoxification
• Lofexidine or Clonidine detoxification
• Prescribes buprenorphine
• Relapse prevention with naltrexone
• Prescribes naltrexone

Other Services

• Treatment for other addiction disorder
• Treatment for gambling disorder

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity

Special Programs/Groups Offered

• Pregnant/postpartum women
• Clients with co-occurring pain and substance use disorders

Age Groups Accepted

• Children/Adolescents

Assessment/Pre-treatment

• Screening for tobacco use
• Screening for mental disorders
• Professional interventionist/educational consultant
• Screening for substance use
• Comprehensive substance use assessment
• Comprehensive mental health assessment

Detoxification (medical withdrawal) Services

• Medication routinely used during detoxification
• Opioids detoxification
• Cocaine Detoxification
• Methamphetamines detoxification
• Benzodiazepines Detoxification
• Alcohol Detoxification

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient detoxification
• Outpatient methadone/buprenorphine or naltrexone treatment
• Regular outpatient treatment
• Outpatient

Transitional Services

• Outcome follow-up after discharge
• Aftercare/continuing care

Payment/Insurance/Funding Accepted

• Cash or self-payment

Education and Counseling Services

• Substance use disorder education
• Smoking/vaping/tobacco cessation counseling
• Individual counseling
• Group counseling
• Hepatitis education, counseling, or support

Treatment Approaches

• Telemedicine/telehealth therapy
• Relapse prevention
• Substance use disorder counseling
• Motivational interviewing
• Brief intervention

Pharmacotherapies

• Buprenorphine (extended-release, injectable)
• Non-nicotine smoking/tobacco cessation
• Medications for Hepatitis C treatment
• Medication for mental disorders
• Clonidine
• Acamprosate (Campral®)
• Buprenorphine without naloxone
• Naltrexone (extended-release, injectable)
• Buprenorphine with naloxone
• Naltrexone (oral)
• Nicotine replacement

Facility Smoking Policy

• Smoking permitted in designated area

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Testing

• Drug or alcohol urine screening
• Testing for Hepatitis C (HCV)
• Testing for Hepatitis B (HBV)
• Breathalyzer or blood alcohol testing
• HIV testing

Type of Care

• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Detoxification
• Substance use treatment